Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo

Background. None of treatment options for Cholangiocarcinoma (CCA), including surgery, adjuvant radiotherapy and chemotherapy, and ultimately liver transplantation, have been shown to substantially improve the survival rate in patients with CCA. Valproic acid (VPA), a histone deacetylase inhibitor,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wang, Bing, Yang, Rui, Wu, Yue, Li, Hongbo, Hu, Zouxiao, Chen, Yongjun, Zou, Shengquan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3845332/
https://ncbi.nlm.nih.gov/pubmed/24324485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/374593
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak